La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Green Thumb Industries a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Green Thumb Industries..

Green Thumb Industries (OTC:GTBIF) Azioni, Catena delle Opzioni

Green Thumb Industries

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 97 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RYTHM.

GREEN THUMB INDUS SUB VTG by Green Thumb Industries Inc.

Green Thumb Industries Inc

VanEck CEO Jan van Eck has made waves with a bold forecast: <a href="https://www.benzinga.com/startups/24/10/41434521/tesla-quietly-transfers-765-million-in-bitcoin-putting-musks-cryptocurrency-strategy-under-intense-s">Bitcoin </a>could skyrocket to $300,000 within five to 10 years. This optimistic projection rests on Bitcoin's ability to capture a substantial share of the gold market – a market long valued as a hedge against inflation.&nbsp;
Don't Miss:
<ul>
<li>Over the last five years, the price of gold has increased by approximately 83% – Investors like Bill O&#8217;Reilly and Rudy Giuliani are using this platform to <a href="https://www.benzinga.com/money/american-hartford-gold">create customized gold IRAs to help shield their savings from inflation and economic turbulence. </a></li>
<li>1 in four Americans own a share of Bitcoin according to Nasdaq – <a href="https://www.benzinga.com/money/binance-100">this platform touts returns as high as 12.5% APY and is giving $100 in welcome rewards if you sign up today.</a></li>
</ul>
According to van Eck, the rise of traditional financial institutions (or "TradFi") investing in Bitcoin drives this trend, with many viewing it as a digital alternative to gold. Van Eck suggested that Bitcoin could eventually reach half of gold's current market capitalization, giving the cryptocurrency a total valuation close to $7 trillion.&nbsp;
Recent data from CoinGecko aligns with this bullish outlook. Bitcoin recently set a record above $89,000, although it settled back to around $90,000 shortly after. Individual investors are jumping into Bitcoin ETFs, a trend that JPMorgan analysts expect to continue through 2025. These ETFs are increasingly seen as a sign that retail and institutional investors trust Bitcoin as a potential "digital gold."
Trending: This well known prop trading firm is offering 100% of your first $25,000 profit per account and 90% after that. <a href="https://www.benzinga.com/money/apex-trader-funding">Here's how to get a special 50% OFF CODE that lets you start out with monthly investments as low as $147 today.</a>
Michael Saylor, CEO of MicroStrategy and a known Bitcoin advocate, pointed out that in the future, bitcoin would be more valuable than gold. "Bitcoin is certainly at least digital gold, it's going to eat gold," Saylor said. "It's got all of the great attributes of gold and it's got none of the defects of gold."
However, Bitcoin's journey toward mainstream acceptance hasn't been without its skeptics. Critics caution that Bitcoin's notorious volatility might limit its role as a stable store of value. Regulatory uncertainty and high energy consumption also cast a shadow over its future.&nbsp;
Yet van Eck remains confident. Calling his prediction of $300,000 per Bitcoin a "reasonable base assumption," he emphasized his belief that the digital asset is increasingly embraced as a long-term store of value.&nbsp;
See Also: If you invested $100 in DOGE when Elon Musk first tweeted about it in 2019,<a href="https://www.benzinga.com/money/etoro-doge"> here&#8217;s how much you&#8217;d have today</a>.
<a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40937953/larry-fink-defies-blackrocks-largest-shareholder-to-make-a-bold-bet-on-bitcoin-heres-how-h">BlackRock CEO Larry Fink</a> echoed similar sentiments, describing Bitcoin as "an asset class by itself" and highlighting its potential value if regulatory clarity improves. "There's more to Bitcoin than meets the eye," Fink said, adding that its uniqueness could enhance its future relevance in finance.
The increasing popularity of Bitcoin ETFs supports van Eck's forecast. According to Investopedia,<a href="https://www.benzinga.com/24/11/41869353/massive-day-for-blackrocks-bitcoin-etf-as-trading-volume-reaches-unseen-levels-with-4-1-billion-traded"> BlackRock's Bitcoin ETF, IBIT,</a> has been outperforming its iShares Gold ETF in trading volume and value growth.
October saw some of the highest single-day inflows for Bitcoin ETFs, underscoring growing investor interest. BlackRock's IBIT ETF has shown steady gains, with its recent performance of $1.12 billion inflows, suggesting that demand for Bitcoin is not slowing down anytime soon.
Read Next:
<ul>
<li>Dogecoin millionaires are increasing –<a href="https://www.benzinga.com/money/dogecoin-millionaires"> investors with $1M+ in DOGE revealed!</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

VanEck CEO Boldly Predicts Bitcoin At $300K Per Coin, Reaching Half Of Gold's Market Cap In The Face Of Growing Demand

Barclays analyst Raimo Lenschow maintains Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) with a Overweight and raises the price target from $19 to $23.

News

Price Target

Analyst Ratings

BASE

Barclays Maintains Overweight on Couchbase, Raises Price Target to $23

Trading Ideas

AREN

The Arena Group Shares Halted On Circuit Breaker To the Upside, Stock Now Up 259.6%

<a href="https://apnews.com/article/general-motors-layoffs-cost-cutting-5e2cc6f8a3210ea364d670a1902a7c65#:~:text=DETROIT%20(AP)%20%E2%80%94%20General%20Motors,statement%20but%20gave%20few%20details.">https://apnews.com/article/general-motors-layoffs-cost-cutting-5e2cc6f8a3210ea364d670a1902a7c65#:~:text=DETROIT%20(AP)%20%E2%80%94%20General%20Motors,statement%20but%20gave%20few%20details.</a>
DETROIT (AP) — General Motors is laying off about 1,000 workers worldwide, shedding costs as it tries to compete in a crowded global automobile market.
The workers, mostly white collar, were notified about the decisions early Friday. The company confirmed the layoffs in a statement but gave few details.
"We need to optimize for speed and excellence," the statement said. "This includes operating with efficiency, ensuring we have the right team structure and focusing on our top priorities."
GM and other automakers have been navigating an uncertain transition to electric vehicles both in the U.S. and worldwide, trying to figure out where to invest capital and how fast the switch will happen.
The company has had to develop and update gas-powered models while investing in EV battery and assembly plants as well as minerals and other parts for the next generation of electric vehicles.
Through September, U.S. new EV sales are up 7.2% to about 936,000, according to <a href="http://motorintelligence.com/">Motorintelligence.com</a>. That's slower growth than the 47% increase in 2023. But EV sales this year are likely to surpass last year's record of 1.19 million, and the EV share of new vehicle sales this year is 7.9%, up from 7.6% last year.

Management

'General Motors Lays Off About 1,000 Workers, Cutting Costs To Compete In A Crowded Automobile Market' - AP

Cantor Fitzgerald analyst Li Watsek reiterates Ascendis Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASND#NASDAQ">ASND</a>) with a Overweight and maintains $170 price target.

Reiteration

ASND

Cantor Fitzgerald Reiterates Overweight on Ascendis Pharma, Maintains $170 Price Target

<a href="https://www.cnbc.com/2024/11/15/elon-musks-xai-raising-up-to-6-billion-to-purchase-100000-nvidia-chips-for-memphis-data-center.html" title="https://www.cnbc.com/2024/11/15/elon-musks-xai-raising-up-to-6-billion-to-purchase-100000-nvidia-chips-for-memphis-data-center.html">https://www.cnbc.com/2024/11/15/elon-musks-xai-raising-up-to-6-billion-to-purchase-100000-nvidia-chips-for-memphis-data-center.html</a>

DXYZ

NVDA

Musk's xAI Seeking Up To $6B In New Funding, Projected Post-Raise Valuation Over $50B; Middle Eastern Sovereign Funds Expected As Key Investors, Funds To Support Purchase Of 100,000 H100s For Memphis Cloud Cluster

Xcel Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELB#NASDAQ">XELB</a>) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.11) by 254.55 percent. This is a 160 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $1.90 million which beat the analyst consensus estimate of $1.60 million by 18.75 percent. This is a 27.95 percent decrease over sales of $2.64 million the same period last year.

Earnings

XELB

Xcel Brands Q3 EPS $(0.39) Misses $(0.11) Estimate, Sales $1.90M Beat $1.60M Estimate

Cantor Fitzgerald analyst C J Muse reiterates Applied Mat (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>) with a Overweight and maintains $250 price target.

AMAT

Cantor Fitzgerald Reiterates Overweight on Applied Mat, Maintains $250 Price Target

Cantor Fitzgerald analyst Kristen Kluska reiterates Codexis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXS#NASDAQ">CDXS</a>) with a Overweight and maintains $11 price target.

CDXS

Cantor Fitzgerald Reiterates Overweight on Codexis, Maintains $11 Price Target

Barclays analyst Gena Wang maintains bluebird bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLUE#NASDAQ">BLUE</a>) with a Overweight and lowers the price target from $4 to $2.

BLUE

Barclays Maintains Overweight on bluebird bio, Lowers Price Target to $2

Barclays analyst Saket Kalia maintains Autodesk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADSK#NASDAQ">ADSK</a>) with a Overweight and raises the price target from $310 to $355.

ADSK

Barclays Maintains Overweight on Autodesk, Raises Price Target to $355

Sigma Lithium Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGML#NASDAQ">SGML</a>) reported a third-quarter revenue of $20.9 million, missing the <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42003367/sigma-lithium-announces-3q24-results-production-beats-guidance-maintained-low-costs-at-target-gene" rel="noreferrer noopener">consensus of $72.5 million</a>.
Sales revenue for shipments stood at $44.2 million in the quarter and Concentrate sold came in at 57,483 tonnes vs. 52,572 tonnes in the second quarter of 2024.
Sigma Lithium delivered strong operational results at its Greentech industrial plant in the third quarter, producing 60,237 tonnes of Quintuple Zero Lithium Concentrate, an increase of 22% quarter over quarter and exceeding the 60,000 tonnes guidance.
This performance included multiple daily production records and sustained operations above 860 tonnes per day.
In the third-quarter, Sigma Lithium achieved one of the industry&#8217;s lowest cash unit operating costs, with CIF China averaging $513/ tonnes, slightly down from $515/ tonnes in the second quarter of 2024.
At the Grota do Cirilo operations, cash unit operating costs for lithium concentrate averaged $395/t, including a temporary $25/t expense for mobile crushers.
The company reported cash adjusted EBITDA&nbsp;loss of $10.6 million and EBITDA loss of $12.8 million in the quarter. Loss per share of $0.23&nbsp;missed <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">the EPS consensus of $0.07</a>.
Sigma Lithium ended the third quarter with&nbsp;cash and cash equivalents of $65.6 million, and operating cash flow stood at&nbsp;$34 million&nbsp;in the third quarter.
Outlook: The company anticipates fourth-quarter production <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">to reach at least 60,000 tonnes</a>.
Ana Cabral, Co-Chairperson and CEO said,&nbsp;&#8220;This quarter we achieved our production and low industry cost targets, generating robust free cash flow and demonstrating our operational resilience to lithium cycles.&#8221;
&#8221;We also benefited from our shifted commercial strategy to navigate industry seasonality, enabling us to secure higher average realized prices compared to benchmarks.&#8221;
Investors can gain exposure to the stock via&nbsp;Sprott Lithium Miners ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LITP#NASDAQ">LITP</a>) and VanEck Rare Earth and Strategic Metals ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REMX#NYSE">REMX</a>).
Price Action: SGML shares are down 2.66% at $12.80 at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/42000168" target="_blank" rel="noreferrer noopener">Pro-Bitcoin Argentina President Javier Milei Becomes First Foreign Leader To Meet Trump: &#8216;Winds Of Freedom Are Blowing Much Stronger&#8217;</a></li>
</ul>

Equities

Small Cap

LITP

Market Vectors Rare Earth/Strategic Metals Etf

REMX

SGML

Sigma Lithium Misses Q3 Revenue and EPS Targets Despite Production Gains

Dividends

FXNC

First National Increases Quarterly Dividend From $0.15 To $0.155

-Reuters Exclusive, Citing Sources

JPMorgan Reportedly Weighing Options For Its European HQ In London, May Build New Tower

Cantor Fitzgerald analyst Louise Chen reiterates Spero Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRO#NASDAQ">SPRO</a>) with a Overweight.

SPRO

Cantor Fitzgerald Reiterates Overweight on Spero Therapeutics

Canaccord Genuity analyst Whitney Ijem maintains Taysha Gene Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSHA#NASDAQ">TSHA</a>) with a Buy and raises the price target from $6 to $8.

TSHA

Canaccord Genuity Maintains Buy on Taysha Gene Therapies, Raises Price Target to $8

Lowe's Companies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LOW#NYSE">LOW</a>) short percent of float has risen 3.36% since its last report. The company recently reported that it has 6.99 million shares sold short, which is 1.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.15 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Lowe's Companies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731681023_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Lowe's Companies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Lowe's Companies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Lowe's Companies's peer group average for short interest as a percentage of float is 6.07%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Lowe's Companies's Recent Short Interest

Cipher Mining's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NYSE">CIFR</a>) short percent of float has risen 3.6% since its last report. The company recently reported that it has 24.14 million shares sold short, which is 11.51% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.27 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Cipher Mining Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731681017_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cipher Mining has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Cipher Mining's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Cipher Mining's peer group average for short interest as a percentage of float is 10.97%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CIFR

Peering Into Cipher Mining's Recent Short Interest

NNN REIT's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNN#NYSE">NNN</a>) short percent of float has risen 25.67% since its last report. The company recently reported that it has 5.19 million shares sold short, which is 3.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.82 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>NNN REIT Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731681012_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for NNN REIT has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing NNN REIT's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, NNN REIT's peer group average for short interest as a percentage of float is 4.73%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(NNN) - Analyzing NNN REIT's Short Interest

Canaccord Genuity analyst William Plovanic maintains TriSalus Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLSI#NASDAQ">TLSI</a>) with a Buy and lowers the price target from $12 to $11.

TLSI

Canaccord Genuity Maintains Buy on TriSalus Life Sciences, Lowers Price Target to $11

Here are the major earnings after the close today

In this edition of "Rising High," The Fly conducted an exclusive interview with Adam Wilks, Co-Founder and CEO of Carma HoldCo, a house of brands f...

Rising High: Exclusive talk with house of brands Carma HoldCo

Green Thumb Industries&nbsp; GAAP EPS of $0.04 misses by $0.02, revenue of $287M beats by $4.06M

Green Thumb Industries, Inc. (GTBIF) Q3 2024 Earnings Call Transcript

Green Thumb's Q3 financial metrics were poor across the board.

Green Thumb Q3 Results Show 58% Decline In Net Income And 5% Decline In EBITDA

In a report released today, Mike Hickey from Benchmark Co. maintained a Buy rating on Green Thumb Industries (GTBIF – Research Report), with a pric...

Benchmark Co. Sticks to Its Buy Rating for Green Thumb Industries (GTBIF)

Haywood analyst Neal Gilmer maintained a Buy rating on Green Thumb Industries (GTBIF – Research Report) today and set a price target of C$24.00. Th...

Haywood Sticks to Their Buy Rating for Green Thumb Industries (GTBIF)

In a report released today, Neal Gilmer from Haywood maintained a Buy rating on Green Thumb Industries (GTBIF – Research Report), with a price targ...

Haywood Remains a Buy on Green Thumb Industries (GTBIF)

Weed stocks spike after report on Trump support for marijuana reforms

Cannabis stocks gain as Trump picks pro-marijuana Congressman Gaetz for AG post

AAOI

AAON

AAWH

ACHR

ACHV

ACRHF

ADMA

ADPT

AEYE

AFRM

AKAM

ALLO

ALRM

ALTM

AMPL

AMRC

ANET

ARCT

ARLO

ARRY

ASLE

ATAI

AYRWF

CANN

CMPS

CNBS

CRLBF

CRON

CURLF

CVSI

DOCS

DVAX

FIVN

FNKO

FOSL

GSBD

GTBIF

HASI

HEAR

INDI

INGN

JUSHF

MSOS

NWSA

OPEN

OUST

PACB

PARA

PBPB

PBYI

PHUN

PINS

PLNH

PODD

PRCH

PTCT

PTMN

QDEL

RCEL

RCMT

RDFN

REZI

RIGL

RIVN

RLMD

SAND

SEMR

SENS

SIGA

TCNNF

TLRY

TSNDF

VREOF

VRNOF

YOLO

Press Releases

Green Thumb Industries Reports Second Quarter 2024 Results

General

Green Thumb Opens Its 20th Florida Location, RISE Dispensary Jacksonville, on September 13

Financing

Green Thumb Industries Refinances its Senior Debt Via Syndicated Credit Facility

Valley Bank's New Jersey Commercial Banking Team Closes a $150 Million Syndicated Credit Facility to Green Thumb Industries Inc.

Green Thumb Industries Announces $50 Million Share Repurchase Program

Green Thumb Industries to Hold Third Quarter 2024 Earnings Conference Call on November 7, 2024

Restaurants

Magnolia Bakery and incredibles Expand Partnership, Bringing Cannabis-Infused Chocolate Treats to RISE Dispensaries in New York and New Jersey

Agrify Secures Financing from Green Thumb Industries and Announces New Leadership

Green Thumb Expands Florida Retail Footprint with the Opening of RISE Orlando on Good Homes Road on November 8

Comments

Green Thumb Industries

Green Thumb Industries (GTBIF) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO